Nongenomic signaling pathways of estrogen toxicity

Toxicological Sciences

Volumn 115, Issue 1, 2010, Pages 1-11

  Watson, Cheryl S ^a   Jeng, Yow Jiun ^a   Kochukov, Mikhail Y ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Membrane estrogen receptors; Signaling; Xenoestrogen

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; COUMESTROL; DAIDZEIN; DIELDRIN; DIETHYLSTILBESTROL; ENDOSULFAN; ESTRADIOL; ESTRIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE; GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHENOL DERIVATIVE; RESVERATROL; XENOBIOTIC AGENT;

APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; DOSE RESPONSE; ENZYME ACTIVITY; HORMONE ACTION; HORMONE STRUCTURE; HUMAN; HYPOPHYSIS; LIPOPHILICITY; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; ANIMAL; CELL MEMBRANE; CHEMISTRY; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; METABOLISM; PHOSPHORYLATION;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; ENVIRONMENTAL EXPOSURE; ESTROGENS, NON-STEROIDAL; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PITUITARY GLAND; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; XENOBIOTICS;

EID: 79551682463     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfp288     Document Type: Review

References (106)

1. Adams, A. B. (1992). Human breast cancer: concerted role of diet, prolactin and adrenal C19-delta 5 steroids in tumorigenesis. Int. J. Cancer 50, 854-858.
2. Adlercreutz, H. (1995). Phytoestrogens: epidemiology and a possible role in cancer protection. Environ. Health Perspect.103(Suppl. 7), 103-112. (Review).
3. Adlercreutz, H., Fotsis, T., Lampe, J., Wahala, K., Makela, T., Brunow, G., and Hase, T. (1993). Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas chromatography-mass spectrometry. Scand. J. Clin. Lab. Invest. Suppl. 215, 5-18.
4. Alonso-Magdalena, P., Ropero, A. B., Carrera, M. P., Cederroth, C. R., Baquie, M., Gauthier, B. R., Nef, S., Stefani, E., and Nadal, A. (2008). Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS. One 3, e2069.
5. Alyea, R. A., Laurence, S. E., Kim, S. H., Katzenellenbogen, B. S., Katzenellenbogen, J. A., and Watson, C. S. (2008). The roles of membrane estrogen receptor subtypes in modulating dopamine transporters in PC-12 cells. J. Neurochem. 106, 1525-1533.
6. Alyea, R. A., and Watson, C. S. (2009a). Differential regulation of dopamine transporter function and location by low concentrations of environmental estrogens and 17beta-estradiol. Environ. Health Perspect. 117, 778-783.
7. Alyea, R. A., and Watson, C. S. (2009b). Nongenomic mechanisms of physiological estrogen-mediated dopamine efflux. BMC Neurosci. 10, 59.
8. Azuma, K., and Inoue, S. (2004). Selective estrogen receptor modulators: mechanisms of action and their tissue selectivity. Clin. Calcium 14(10), 12-26.
9. Benedetti, M. D., Maraganore, D. M., Bower, J. H., McDonnell, S. K., Peterson, B. J., Ahlskog, J. E., Schaid, D. J., and Rocca, W. A. (2001). Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study. Mov. Disord. 16, 830-837.
10. Bickoff, E. M., Booth, A. N., Lyman, R. L., Livingston, A. L., Thompson, C. R., and Deeds, F. (1957). Coumestrol, a new estrogen isolated from forage crops. Science 126, 969-970.
11. Boonyaratanakornkit, V., Scott, M. P., Ribon, V., Sherman, L., Anderson, S. M., Maller, J. L., Miller, W. T., and Edwards, D. P. (2001). Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol. Cell 8, 269-280.
12. Bouskine, A., Nebout, M., Brucker-Davis, F., Benahmed, M., and Fenichel, P. (2009). Low doses of bisphenol A promote human seminoma cell proliferation by activating PKA and PKG via a membrane G-proteincoupled estrogen receptor. Environ. Health Perspect. 117, 1053-1058.
13. Brownson, D. M., Azios, N. G., Fuqua, B. K., Dharmawardhane, S. F., and Mabry, T. J. (2002). Flavonoid effects relevant to cancer. J. Nutr. 132(Suppl. 11), 3482S-3489S.
14. Bulayeva, N. N., Gametchu, B., and Watson, C. S. (2004). Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways. Steroids 69, 181-192.
15. Bulayeva, N. N., and Watson, C. S. (2004). Xenoestrogen-induced ERK-1 and ERK-2 activation via multiple membrane-initiated signaling pathways. Environ. Health Perspect. 112, 1481-1487.
16. Campbell, C. H., Bulayeva, N., Brown, D. B., Gametchu, B., and Watson, C. S. (2002). Regulation of the membrane estrogen receptor-alpha: role of cell density, serum, cell passage number, and estradiol. FASEB J. 16, 1917-1927.
17. Cao, T. T., Mays, R. W., and von Zastrow, M. (1998). Regulated endocytosis of G-protein-coupled receptors by a biochemically and functionally distinct subpopulation of clathrin-coated pits. J. Biol. Chem. 273, 24592-24602.
18. Cao, Z., West, C., Norton-Wenzel, C. S., Rej, R., Davis, F. B., Davis, P. J., and Rej, R. (2009). Effects of resin or charcoal treatment on fetal bovine serum and bovine calf serum. Endocr. Res. 34, 101-108.
19. Carreau, S., and Levallet, J. (2000). Testicular estrogens and male reproduction. News Physiol. Sci. 15, 195-198.
20. Catterall, J. F., Watson, C. S., Kontula, K. K., Janne, O. A., and Bardin, C. W. (1985). Differential sensitivity of specific genes in mouse kidney to androgens and antiandrogens. In Molecular Mechanisms of Steroid Hormone Action (V. K. Moudgil, Ed.), pp. 587-602. Walter de Gruyter, New York.
21. Chambliss, K. L., and Shaul, P. W. (2002). Rapid activation of endothelial NO synthase by estrogen: evidence for a steroid receptor fast-action complex (SRFC) in caveolae. Steroids 67, 413-419.
22. Chard, T., and Macintosh, M. C. (1995). Screening for Down's syndrome. J. Perinat. Med. 23, 421-436.
23. Clevenger, C. V., Furth, P. A., Hankinson, S. E., and Schuler, L. A. (2003). The role of prolactin in mammary carcinoma. Endocr. Rev. 24, 1-27.
24. Colborn, T. (2004). Neurodevelopment and endocrine disruption. Environ. Health Perspect. 112, 944-949.
25. Compton, J., van, A. T., and Murphy, D. (2002). Mood, cognition and Alzheimer's disease. Best. Pract. Res. Clin. Obstet. Gynaecol. 16, 357-370.
26. Cornwell, T., Cohick, W., and Raskin, I. (2004). Dietary phytoestrogens and health. Phytochemistry 65, 995-1016.
27. Dannies, P. S. (1985). Control of prolactin production by estrogen. In Biochemical Actions of Hormones, 12th ed. (G. Litwack, Ed.), pp. 289-310. Academic Press, Inc., Orlando, FL.
28. Delbes, G., Levacher, C., and Habert, R. (2006). Estrogen effects on fetal and neonatal testicular development. Reproduction 132, 527-538.
29. Dluzen, D. E., and Mickley, K. R. (2005). Gender differences in modulatory effects of tamoxifen upon the nigrostriatal dopaminergic system. Pharmacol. Biochem. Behav. 80, 27-33.
30. Filardo, E. J., and Thomas, P. (2005). GPR30: a seven-transmembranespanning estrogen receptor that triggers EGF release. Trends Endocrinol. Metab 16, 362-367.
31. Foltynie, T., Lewis, S. G., Goldberg, T. E., Blackwell, A. D., Kolachana, B. S., Weinberger, D. R., Robbins, T. W., and Barker, R. A. (2005). The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease. J. Neurol. 252, 833-838.
32. Fritz, W. A., Coward, L., Wang, J., and Lamartiniere, C. A. (1998). Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. Carcinogenesis 19, 2151-2158.
33. Fukazawa, H., Hoshino, K., Shiozawa, T., Matsushita, H., and Terao, Y. (2001). Identification and quantification of chlorinated bisphenol A in wastewater from wastepaper recycling plants. Chemosphere 44, 973-979.
34. Gaido, K. W., Leonard, L. S., Lovell, S., Gould, J. C., Babai, D., Portier, C. J., and McDonnell, D. P. (1997). Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol. Appl. Pharmacol. 143, 205-212.
35. Gallard, H., Leclercq, A., and Croue, J. P. (2004). Chlorination of bisphenol A: kinetics and by-products formation. Chemosphere 56, 465-473.
36. Gehm, B. D., McAndrews, J. M., Chien, P. Y., and Jameson, J. L. (1997). Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. U.S.A. 94, 14138-14143.
37. Gorski, J., Wendell, D., Gregg, D., and Chun, T. Y. (1997). Estrogens and the genetic control of tumor growth. Prog. Clin. Biol. Res. 396, 233-243. (Review).
38. Greenspan, F. S., and Gardner, D. G. (2004). In Basic and Clinical Endocrinology, pp. 925-926. Lange Medical Books, McGraw Hill, New York.
39. Gross, B., Montgomery-Brown, J., Naumann, A., and Reinhard, M. (2004). Occurrence and fate of pharmaceuticals and alkylphenol ethoxylate metabolites in an effluent-dominated river and wetland. Environ. Toxicol. Chem. 23, 2074-2083.
40. Gutendorf, B., and Westendorf, J. (2001). Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens. Toxicology 166(1-2), 79-89.
41. Gutzman, J. H., Miller, K. K., and Schuler, L. A. (2004). Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells. J. Steroid Biochem. Mol. Biol. 88(1), 69-77.
42. Hotchkiss, A. K., Rider, C. V., Blystone, C. R., Wilson, V. S., Hartig, P. C., Ankley, G. T., Foster, P. M., Gray, C. L., and Gray, L. E. (2008). Fifteen years after "Wingspread"-environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go. Toxicol. Sci. 105, 235-259.
43. Howells, L. M., Neal, C. P., Brown, M. C., Berry, D. P., and Manson, M. M. (2008). Indole-3-carbinol enhances anti-proliferative, but not anti-invasive effects of oxaliplatin in colorectal cancer cell lines. Biochem. Pharmacol. 75, 1774-1782.
44. Hu, J. Y., Xie, G. H., and Aizawa, T. (2002). Products of aqueous chlorination of 4-nonylphenol and their estrogenic activity. Environ. Toxicol. Chem. 21, 2034-2039.
45. Jansson, L., and Holmdahl, R. (2001). Enhancement of collagen-induced arthritis in female mice by estrogen receptor blockage. Arthritis Rheum. 44, 2168-2175.
46. Jeng, Y. J., Kochukov, M. Y., and Watson, C. S. (2009). Membrane estrogen receptor-alpha-mediated nongenomic actions of phytoestrogens in GH3/B6/F10 pituitary tumor cells. J. Mol. Signal. 4, 2.
47. Jeng, Y. J., and Watson, C. S. (2009). Proliferative and anti-proliferative effects of dietary levels of phytoestrogens in rat pituitary GH3/B6/F10 cells-the involvement of rapidly activated kinases and caspases. BMC Cancer 9, 334.
48. Kloas, W., Lutz, I., and Einspanier, R. (1999). Amphibians as a model to study endocrine disruptors: II. Estrogenic activity of environmental chemicals in vitro and in vivo. Sci. Total Environ. 225, 59-68.
49. 6/F10 somatomammotropes. Environ. Health Perspect. 117, 723-730.
50. Kolpin, D. W., Furlong, E. T., Meyer, M. T., Thurman, E. M., Zaugg, S. D., Barber, L. B., and Buxton, H. T. (2002). Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 36, 1202-1211.
51. Kuiper, G. G., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der, B. B., and Gustafsson, J. A. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139, 4252-4263.
52. Kurlan, R. (1992). The pathogenesis of Tourette's syndrome. A possible role for hormonal and excitatory neurotransmitter influences in brain development. Arch. Neurol. 49, 874-876.
53. Kwack, S. J., Kwon, O., Kim, H. S., Kim, S. S., Kim, S. H., Sohn, K. H., Lee, R. D., Park, C. H., Jeung, E. B., An, B. S., et al. (2002). Comparative evaluation of alkylphenolic compounds on estrogenic activity in vitro and in vivo. J. Toxicol. Environ. Health A. 65, 419-431.
54. Lakind, J. S., and Naiman, D. Q. (2008). Bisphenol A (BPA) daily intakes in the United States: estimates from the 2003-2004 NHANES urinary BPA data. J. Expo. Sci. Environ. Epidemiol. 18, 608-615.
55. Liu, X. F., and Bagchi, M. K. (2004). Recruitment of distinct chromatinmodifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo. J. Biol. Chem. 279, 15050-15058.
56. Lu, M. L., Schneider, M. C., Zheng, Y., Zhang, X., and Richie, J. P. (2001). Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J. Biol. Chem. 276, 13442-13451.
57. Mao, J. J., Stricker, C., Bruner, D., Xie, S., Bowman, M. A., Farrar, J. T., Greene, B. T., and Demichele, A. (2009). Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors. Cancer 115, 3631-3639.
58. McKinlay, R., Plant, J. A., Bell, J. N., and Voulvoulis, N. (2008). Calculating human exposure to endocrine disrupting pesticides via agricultural and nonagricultural exposure routes. Sci. Total Environ. 398, 1-12.
59. Meinhardt, U., and Mullis, P. E. (2002). The essential role of the aromatase/p450arom. Semin. Reprod. Med. 20, 277-284.
60. Michel, M. C., and Alewijnse, A. E. (2007). Ligand-directed signaling: 50 ways to find a lover. Mol. Pharmacol. 72, 1097-1099.
61. Morley, P., Whitfield, J. F., Vanderhyden, B. C., Tsang, B. K., and Schwartz, J. (1992). A new, nongenomic estrogen action: the rapid release of intracellular calcium. Endocrinology 131, 1305-1312.
62. Mueller, A., and Gooren, L. (2008). Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones. Eur. J. Endocrinol. 159, 197-202.
63. Mustafa, A. M., Malintan, N. T., Seelan, S., Zhan, Z., Mohamed, Z., Hassan, J., Pendek, R., Hussain, R., and Ito, N. (2007). Phytoestrogens levels determination in the cord blood from Malaysia rural and urban populations. Toxicol. Appl. Pharmacol. 222, 25-32.
64. Myers, J. P., Zoeller, R. T., and vom Saal, F. S. (2009). A clash of old and new scientific concepts in toxicity, with important implications for public health. Environ. Health Perspect. (Forthcoming).
65. Nadal, A., Alonso-Magdalena, P., Soriano, S., Quesada, I., and Ropero, A. B. (2009). The pancreatic beta-cell as a target of estrogens and xenoestrogens: implications for blood glucose homeostasis and diabetes. Mol. Cell Endocrinol. 304, 63-68.
66. Narita, S. I., Goldblum, R. M., Watson, C. S., Brooks, E. G., Estes, D. M., Curran, E. M., and Midoro-Horiuti, T. (2007). Environmental estrogens induce mast cell degranulation and enhance IgE-mediated release of allergic mediators PMCID: 17366818. Environ. Health Perspect. 115, 48-52.
67. National Center for Biotechnology Information. (2009). PubChem. Bethesda, MD: National Library of Medicine National Institutes of Health. (Electronic Citation).
68. Nevalainen, M. T., Valve, E. M., Ingleton, P. M., Nurmi, M., Martikainen, P. M., and Harkonen, P. L. (1997). Prolactin and prolactin receptors are expressed and functioning in human prostate. J. Clin. Invest. 99, 618-627.
69. Norman, A. W., Olivera, C. J., Barreto Silva, F. R., and Bishop, J. E. (2002). A specific binding protein/receptor for 1alpha,25-dihydroxyvitamin D(3) is present in an intestinal caveolae membrane fraction. Biochem. Biophys. Res. Commun. 298, 414-419.
70. Otto, C., Fuchs, I., Altmann, H., Klewer, M., Schwarz, G., Bohlmann, R., Nguyen, D., Zorn, L., Vonk, R., Prelle, K., et al. (2008). In vivo characterization of estrogen receptor modulators with reduced genomic versus nongenomic activity in vitro. J. Steroid Biochem. Mol. Biol. 111(1-2), 95-100.
71. Pappas, T. C., Gametchu, B., Yannariello-Brown, J., Collins, T. J., and Watson, C. S. (1994). Membrane estrogen receptors in GH3/B6 cells are associated with rapid estrogen-induced release of prolactin. Endocrine 2, 813-822.
72. Petrovic, M., Diaz, A., Ventura, F., and Barcelo, D. (2003). Occurrence and removal of estrogenic short-chain ethoxy nonylphenolic compounds and their halogenated derivatives during drinking water production. Environ. Sci. Technol. 37, 4442-4448.
73. Pike, A. C., Brzozowski, A. M., Hubbard, R. E., Bonn, T., Thorsell, A. G., Engstrom, O., Ljunggren, J., Gustafsson, J. A., and Carlquist, M. (1999). Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J. 18, 4608-4618.
74. Quinn, P. O. (2005). Treating adolescent girls and women with ADHD: genderspecific issues. J. Clin. Psychol. 61, 579-587.
75. Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., and Prossnitz, E. R. (2005). A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307, 1625-1630.
76. Rose-Hellekant, T. A., Arendt, L. M., Schroeder, M. D., Gilchrist, K., Sandgren, E. P., and Schuler, L. A. (2003). Prolactin induces ERalphapositive and ERalpha-negative mammary cancer in transgenic mice. Oncogene 22, 4664-4674.
77. Routledge, E. J., and Sumpter, J. P. (1997). Structural features of alkylphenolic chemicals associated with estrogenic activity. J. Biol. Chem. 272, 3280-3288.
78. Selles, J., Polini, N., Alvarez, C., and Massheimer, V. (2005). Novel action of estrone on vascular tissue: regulation of NOS and COX activity. Steroids 70, 251-256.
79. Sheeler, C. Q., Dudley, M. W., and Khan, S. A. (2000). Environmental estrogens induce transcriptionally active estrogen receptor dimers in yeast: activity potentiated by the coactivator RIP140. Environ. Health Perspect. 108, 97-103.
80. Shenhav, S., Gemer, O., Volodarsky, M., Zohav, E., and Segal, S. (2003). Midtrimester triple test levels in women with severe preeclampsia and HELLP syndrome. Acta Obstet. Gynecol. Scand. 82, 912-915.
81. Simons, S. S., Jr. (2008). What goes on behind closed doors: physiological versus pharmacological steroid hormone actions. Bioessays 30, 744-756.
82. Singleton, D. W., Feng, Y., Chen, Y., Busch, S. J., Lee, A. V., Puga, A., and Khan, S. A. (2004). Bisphenol-A and estradiol exert novel gene regulation in human MCF-7 derived breast cancer cells. Mol. Cell Endocrinol. 221, 47-55.
83. Singleton, D. W., and Khan, S. A. (2003). Xenoestrogen exposure and mechanisms of endocrine disruption. Front Biosci. 8, s110-s118.
84. Sobrinho, L. G. (2003). Prolactin, psychological stress and environment in humans: adaptation and maladaptation. Pituitary. 6, 35-39.
85. Song, R. X., Zhang, Z., and Santen, R. J. (2005). Estrogen rapid action via protein complex formation involving ERalpha and Src. Trends Endocrinol. Metab. 16, 347-353.
86. Stahlhut, R. W., Welshons, W. V., and Swan, S. H. (2009). Bisphenol A data in NHANES suggest longer than expected half-life, substantial nonfood exposure, or both. Environ. Health Perspect. 117, 784-789.
87. Steinmetz, R., Brown, N. G., Allen, D. L., Bigsby, R. M., and Benjonathan, N. (1997). The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo. Endocrinology 138, 1780-1786.
88. Tabira, Y., Nakai, M., Asai, D., Yakabe, Y., Tahara, Y., Shinmyozu, T., Noguchi, M., Takatsuki, M., and Shimohigashi, Y. (1999). Structural requirements of para-alkylphenols to bind to estrogen receptor. Eur. J. Biochem. 262, 240-245.
89. Talsness, C. E., Andrade, A. J., Kuriyama, S. N., Taylor, J. A., and vom Saal, F. S. (2009). Components of plastic: experimental studies in animals and relevance for human health. Philos. Trans. R. Soc. Lond. B Biol. Sci. 364, 2079-2096.
90. Thomas, P., and Doughty, K. (2004). Disruption of rapid, nongenomic steroid actions by environmental chemicals: interference with progestin stimulation of sperm motility in Atlantic croaker. Environ. Sci. Technol. 38, 6328-6332.
91. U.S. Department of Health and Human Services. (2005). Agency for Toxic Substances and Disease Registry (ATSDR) 2002 Toxicological profile for aldrin and dieldrin. Available at: http://www.atsdr.cdc.gov/toxprofiles/tp1.pdf. Accessed December 21, 2009.
92. Versteeg, H. H., Nijhuis, E., van den Brink, G. R., Evertzen, M., Pynaert, G. N., van Deventer, S. J., Coffer, P. J., and Peppelenbosch, M. P. (2000). A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-elementbinding protein. Biochem. J 350(Pt 3), 717-722.
93. Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., Jr., and Walle, U. K. (2004). High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos. 32, 1377-1382.
94. Watson, C. S., Alyea, R. A., Jeng, Y. J., and Kochukov, M. Y. (2007). Nongenomic actions of low concentration estrogens and xenoestrogens on multiple tissues PMCID: 17601655. Mol. Cell Endocrinol. 274, 1-7.
95. Watson, C. S., Jeng, Y. J., and Kochukov, M. Y. (2008). Nongenomic actions of estradiol compared with estrone and estriol in pituitary tumor cell signaling and proliferation. FASEB J. 22, 3328-3336.
96. 3/B6 pituitary tumor cells via a plasma membrane version of estrogen receptor-α. Steroids 64, 5-13.
97. Welshons, W. V., Thayer, K. A., Judy, B. M., Taylor, J. A., Curran, E. M., and vom Saal, F. S. (2003). Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ. Health Perspect. 111, 994-1006.
98. Weltje, L., vom Saal, F. S., and Oehlmann, J. (2005). Reproductive stimulation by low doses of xenoestrogens contrasts with the view of hormesis as an adaptive response. Hum. Exp. Toxicol. 24, 431-437.
99. Whitten, P. L., and Patisaul, H. B. (2001). Cross-species and interassay comparisons of phytoestrogen action. Environ. Health Perspect.109(Suppl. 1), 5-20. (Review).
100. Wilkinson, R. F. (1993). The effect of charcoal/dextran treatment on select serum components. Art Sci. Tissue Culture 12(3-4), 1-9.
101. Wozniak, A. L., Bulayeva, N. N., and Watson, C. S. (2005). Xenoestrogens at picomolar to nanomolar concentrations trigger membrane estrogen receptoralpha-mediated Ca2+ fluxes and prolactin release in GH3/B6 pituitary tumor cells. Environ. Health Perspect. 113, 431-439.
102. Wu, Y., Foster, W. G., and Younglai, E. V. (2006). Rapid effects of pesticides on human granulosa-lutein cells. Reproduction 131, 299-310.
103. Wu, J., and Gorenstein, D. G. (1993). Structure and dynamics of cytochrome C in non-aqueous solvents by 2D NH-exchange NMR spectroscopy. J. Am. Chem. Soc. 115, 6843-6850.
104. Yoon, D. Y., Rippel, C.A.,Kobets,A. J.,Morris, C. M., Lee, J. E., Williams, P.N., Bridges, D. D., Vandenbergh, D. J., Shugart, Y. Y., and Singer, H. S. (2007). Dopaminergic polymorphisms in Tourette syndrome: association with the DAT gene (SLC6A3). Am. J. Med. Genet. B Neuropsychiatr. Genet. 144, 605-610.
105. Zivadinovic, D., Gametchu, B., and Watson, C. S. (2005). Membrane estrogen receptor-alpha levels in MCF-7 breast cancer cells predict cAMP and proliferation responses PMCID: 15642158. Breast Cancer Res. 7, R101-R112.
106. Zivadinovic, D., and Watson, C. S. (2005). Membrane estrogen receptor-alpha levels predict estrogen-induced ERK1/2 activation in MCF-7 cells. Breast Cancer Res. 7, R130-R144.